These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. Jirarattanasopa P; Ooto S; Nakata I; Tsujikawa A; Yamashiro K; Oishi A; Yoshimura N Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3663-72. PubMed ID: 22570352 [TBL] [Abstract][Full Text] [Related]
10. Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice. van Wijngaarden P; Qureshi SH Clin Exp Optom; 2008 Sep; 91(5):427-37. PubMed ID: 18637105 [TBL] [Abstract][Full Text] [Related]
11. Pegaptanib for the treatment of age-related macular degeneration. Zhou B; Wang B Exp Eye Res; 2006 Sep; 83(3):615-9. PubMed ID: 16678158 [TBL] [Abstract][Full Text] [Related]
12. Baseline Predictors for Good Versus Poor Visual Outcomes in the Treatment of Neovascular Age-Related Macular Degeneration With Intravitreal Anti-VEGF Therapy. Chae B; Jung JJ; Mrejen S; Gallego-Pinazo R; Yannuzzi NA; Patel SN; Chen CY; Marsiglia M; Boddu S; Freund KB Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5040-7. PubMed ID: 26237196 [TBL] [Abstract][Full Text] [Related]
13. [Introduction to the topic: anti-VEGF therapy in the management of AMD]. Meyer CH Ophthalmologe; 2008 Feb; 105(2):123-4. PubMed ID: 18256843 [No Abstract] [Full Text] [Related]
14. Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study. Sadda SR; Stoller G; Boyer DS; Blodi BA; Shapiro H; Ianchulev T Retina; 2010 Oct; 30(9):1390-9. PubMed ID: 20924261 [TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of age-related macular degeneration: an update for pharmacists. Marshall LL; Roach JM Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192 [TBL] [Abstract][Full Text] [Related]
16. Age-Related Macular Degeneration. Mehta S Prim Care; 2015 Sep; 42(3):377-91. PubMed ID: 26319344 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy. Rush RB; Rush SW; Aragon AV; Ysasaga JE Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972 [TBL] [Abstract][Full Text] [Related]
18. Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration. Boltz A; Ruiß M; Jonas JB; Tao Y; Rensch F; Weger M; Garhöfer G; Frantal S; El-Shabrawi Y; Schmetterer L Ophthalmology; 2012 Aug; 119(8):1615-20. PubMed ID: 22521084 [TBL] [Abstract][Full Text] [Related]
19. Recent developments in age-related macular degeneration: a review. Al-Zamil WM; Yassin SA Clin Interv Aging; 2017; 12():1313-1330. PubMed ID: 28860733 [TBL] [Abstract][Full Text] [Related]